ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RSY Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index AMEX:RSY AMEX Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Recom Managed Systems Strengthens Board of Directors; Adds Los Angeles Business Legend Rowland Perkins

25/08/2005 4:54pm

Business Wire


Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index (AMEX:RSY)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index Charts.
Recom Managed Systems (AMEX:RSY) announced today that it has added two members to its board of directors. Business leader Rowland Perkins, co-founder of one of the top talent and literary agencies in Los Angeles, will serve as a member of the board's compensation committee. Also named to the board was Norma Provencio, who will serve as an independent member of the board's audit committee. Mr. Perkins, who co-founded Creative Artists Agency and served as its president, joined the board effective immediately. Creative Artists Agency, which was co-founded by Hollywood moguls such as Michael Ovitz and Ron Meyer, has acted as one of the most powerful business organizations in the country. It was co-founded by Mr. Perkins in 1975 following his very successful 16-year career with stalwart William Morris Agency. There, Mr. Perkins ultimately supervised the television development division, where he helped introduce the concept of "motion pictures for television" and presided over the development of dozens of television projects, many of which reached the fall schedule. Creative Artists Agency ultimately assisted many national and international companies in broad marketing and business-consulting efforts. Mr. Perkins, who has replaced Lucy Duncan-Scheman, will assist new company chair, Chief Executive Officer Pamela Bunes, in media evaluation and exposure during Recom's critical and ongoing "go-to-market" transition. Ms. Bunes was unanimously voted by the board to serve as its chair now that the company's managerial operations have successfully moved to Greenville, S.C. The company maintains its office, information systems and technical laboratories in Los Angeles. Commenting on the addition of Mr. Perkins, Ms. Bunes said, "We are very gratified that a person of Mr. Perkins' caliber will be available as a board member for consultation and assistance. His experience for two decades at Creative Artists Agency alone -- where that company became a prominent leader in many diversified business services encompassing advertising (Coca-Cola), investment and banking advisement (Sony/Columbia) and other consultation for companies in communications and technology fields -- is experience that represents a perfect fit for us at this juncture in the company's development." Mr. Perkins has also been a longtime member of the Academy of Television Arts and Sciences and has served on its board of governors. He also has been a longtime member of the Hollywood Radio and Television Society and served on its board of directors. Mr. Perkins has been active in consulting and board-membership roles for several successful companies over the past decades. Also added to the audit committee of Recom's board of directors was independent board member Norma Provencio. Ms. Provencio has a 25-year career where she was partner of international accounting firms, the last one being KPMG. Ms. Provencio currently serves as a consultant to health care companies and is active philanthropically through various foundations. Dr. Lowell Harmison, one of Recom's long-term board members for more than two years, commented, "We are very happy to welcome Mr. Perkins and Ms. Provencio. I have personally been very satisfied with how smoothly and quickly the company has developed its East Coast presence through, among other things, the opening of the South Carolina office. As the company now looks to access media and associated commercialization with more focus, the addition of Mr. Perkins is exciting and timely. Continuing to bring on experienced and independent board members -- and financial experts such as Ms. Provencio -- is also salutary and critical to the appropriate constituency of the company's board for purposes of its new national listing on the American Stock Exchange and its continued governance going forward." About Recom Managed Systems, Inc. Recom Managed Systems, Inc. is an emerging life-sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Recom Managed Systems, Inc. uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting. With its patented signal-technology platform, Recom brings clinical-quality physiological signal monitoring to the ambulatory setting. Recom's first product, the Model 100 Heart Monitor, is an ambulatory patient heart monitor that uses patented signal-processing technology to record a clinical-quality ECG signal in the presence of interference generated by the patient's body movements and ambient environment. The Model 100 has received 510(k) clearance from the Food and Drug Administration. Recom Managed Systems, Inc. is traded on the American Stock Exchange under the symbol RSY. More information is located at http://www.recom-systems.com. Caution Regarding Forward-Looking Statements Statements in this release that are not strictly historical are "forward-looking" statements. Forward-looking statements involve known and unknown risks, which may cause Recom's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of new products or services, failure to obtain federal or state regulatory approvals governing medical devices, monitoring and other related services or products, inability to obtain physician, patient or insurance acceptance of Recom's products or services, adverse equity-market conditions and declines in the value of Recom's common stock, and the unavailability of financing to complete management's plans and objectives. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Recom's filings with the Securities and Exchange Commission.

1 Year Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index Chart

1 Year Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index Chart

1 Month Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index Chart

1 Month Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index Chart

Your Recent History

Delayed Upgrade Clock